SCHEMBL28386372

SCHEMBL28386372

O=C(/C=C/C(=O)OCCCN1C(=O)c2ccccc2C1=O)OCCCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.66
KMT2A Q03164 1/20 0.66
SMN1; SMN2 Q16637 3/20 0.58
MAPT P10636 1/20 0.58
RAB9A P51151 1/20 0.58
ALDH1A1 P00352 5/20 0.52
LMNA P02545 3/20 0.52
HPGD P15428 2/20 0.52
TSHR P16473 2/20 0.52
NPSR1 Q6W5P4 1/20 0.52
HDAC7 Q8WUI4 3/20 0.50
MAPK1 P28482 2/20 0.50
HSD17B10 Q99714 1/20 0.50
GLA P06280 1/20 0.49
BRCA1 P38398 1/20 0.49
HDAC8 Q9BY41 3/20 0.49
HDAC3 O15379 2/20 0.49
HDAC4 P56524 2/20 0.49
HDAC1 Q13547 2/20 0.49
HDAC2 Q92769 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9838180 0.88 MEN1 (0.56) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL10640451 0.87 MEN1 (0.59) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL17158253 0.84 ALDH1A1 (0.55) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL16039148 0.84 MEN1 (0.69) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL16039147 0.84 MEN1 (0.69) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL10681970 0.83 MEN1 (0.51) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL10681979 0.83 MEN1 (0.51) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL10495302 0.83 ALDH1A1 (0.70) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL10641570 0.82 MEN1 (0.71) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL10555513 0.81 SMN1; SMN2 (0.62) MEN1KMT2ASMN1; SMN2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107501110-B Fumarate prodrugs and their use in the treatment of various diseases 阿尔克梅斯制药爱尔兰有限公司 2020-05-05 CN disclosed